Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-35590
Irla, M; Küpfer, N; Suter, T; Lissilaa, R; Benkhoucha, M; Skupsky, J; Lalive, P H; Fontana, A; Reith, W; Hugues, S (2010). MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. Journal of Experimental Medicine, 207(9):1891-1905.
View at publisher
Although plasmacytoid dendritic cells (pDCs) express major histocompatibility complex class II (MHCII) molecules, and can capture, process, and present antigens (Ags), direct demonstrations that they function as professional Ag-presenting cells (APCs) in vivo during ongoing immune responses remain lacking. We demonstrate that mice exhibiting a selective abrogation of MHCII expression by pDCs develop exacerbated experimental autoimmune encephalomyelitis (EAE) as a consequence of enhanced priming of encephalitogenic CD4(+) T cell responses in secondary lymphoid tissues. After EAE induction, pDCs are recruited to lymph nodes and establish MHCII-dependent myelin-Ag-specific contacts with CD4(+) T cells. These interactions promote the selective expansion of myelin-Ag-specific natural regulatory T cells that dampen the autoimmune T cell response. pDCs thus function as APCs during the course of EAE and confer a natural protection against autoimmune disease development that is mediated directly by their ability to present of Ags to CD4(+) T cells in vivo.
75 downloads since deposited on 05 Nov 2010
29 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Immunology
04 Faculty of Medicine > Institute of Experimental Immunology
|Dewey Decimal Classification:||570 Life sciences; biology
610 Medicine & health
|Deposited On:||05 Nov 2010 10:25|
|Last Modified:||05 Apr 2016 14:14|
|Publisher:||Rockefeller University Press|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page